AXON
- NASDAQ - Security/Sfty
Axon Enterprise Inc
|
$224.99 |
-2.54 -1.12%
|
$227.50
|
$229.00
|
-1.75% |
708,238 88.09%
|
804,000
|
Most Recent Note for AXON - 4/19/2023 12:26:04 PM
Recently wedging to new all-time highs with gains lacking great volume conviction. Found prompt support after briefly undercutting its 50 DMA line on 2/07/23. Reported strong Dec '22 quarterly results. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Went through a deep consolidation since dropped from the Featured Stocks list on 3/04/21.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZN
- NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
|
$74.61 |
-0.42 -0.55%
|
$74.82
|
$75.83
|
-1.62% |
2,594,873 57.56%
|
4,508,000
|
Most Recent Note for AZN - 4/19/2023 12:28:02 PM
Perched at its all-time high following a volume-driven gain on the prior session when noted with caution in the mid-day report - "Reported Dec '22 quarterly earnings -19% on -7% sales revenues versus the year-ago period. Prior quarterly and annual earnings history does not match the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BLX
- NYSE - BANKING - Foreign Regional Banks
Banco Latinoamericano C
|
$19.19 |
+0.42
2.24%
|
$19.49
|
$19.17
|
0.10% |
72,639 74.89%
|
97,000
|
Most Recent Note for BLX - 4/19/2023 12:30:15 PM
Traded above its Oct '21 high early today while on track for a 9th consecutive gain. Reported Dec '22 quarterly earnings +57% on +206% sales revenues versus the year-ago period. Quarterly comparisons in Jun and Sep '22 also showed very strong sales revenues and earnings increases versus the year-ago periods. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline. Up and down annual earnings (A criteria) history is a concern.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DRD
- NYSE - METALS & MINING - Gold
Drdgold Ltd Adr
|
$10.52 |
-0.36 -3.31%
|
$10.58
|
$11.05
|
-4.80% |
281,643 73.15%
|
385,000
|
Most Recent Note for DRD - 4/19/2023 12:32:02 PM
Reported Dec '22 quarterly earnings +2% on +0% sales revenues versus the year-ago period. Fundamental concerns remain as when noted in the 7/27/20 mid-day report - "This low-priced South African company in the Mining - Gold/Silver/Gems group has an erratic earnings history, not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GLOP
- NYSE - Oil&Gas-Transprt/Pipelne
GasLog Partners LP
|
$8.49 |
+0.03
0.30%
|
$8.49
|
$9.27
|
-8.47% |
644,084 139.11%
|
463,000
|
Most Recent Note for GLOP - 4/19/2023 12:33:12 PM
Still consolidating in a tight range near its 50 DMA line ($8.57). Gapped up on 1/25/23 following M&A news. Reported Dec '22 quarterly earnings +67% on +19% sales revenues versus the year-ago period, its 3rd strong quarterly comparison. Annual earnings history (A criteria) has not been strong and steady and fundamental concerns remain.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HCA
- NYSE - HEALTH SERVICES - Hospitals
H C A Holdings Inc
|
$270.06 |
-1.40 -0.51%
|
$271.11
|
$279.02
|
-3.21% |
726,118 63.20%
|
1,149,000
|
Most Recent Note for HCA - 4/19/2023 12:36:57 PM
Perched within close striking distance of its 52-week high. Reported earnings +5% on +3% sales revenues for the Dec '22 quarter versus the year-ago period, and prior quarterly comparisons were below the +25% minimum earnings (C criteria) guideline. Annual earnings history included a downturn in FY '22. Completed Secondary Offerings on 12/12/12, 10/29/13, and 5/21/14. Has a new CEO as of 1/01/14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IBKR
- NASDAQ - Finance-Invest Bnk/Bkrs
Interactive Brokers Grp
|
$84.10 |
-0.64 -0.76%
|
$85.79
|
$90.19
|
-6.75% |
1,076,068 91.58%
|
1,175,000
|
Most Recent Note for IBKR - 4/19/2023 12:39:42 PM
Rebounding above its 50 DMA line ($83.30) with today's 8th consecutive gain backed by ever-increasing volume. Showed resilience after reversing from a new all-time high on 3/06/23 and violating prior highs in the $81-82 area. Prior mid-day reports cautioned members - "Reported Dec '22 quarterly earnings rose +57% on +131% sales revenues versus the year-ago period, its 2nd strong quarter. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) and fundamentals are not a great match with the fact-based investment system's guidelines. Annual earnings for FY '19 matched the year prior while otherwise its annual earnings (A criteria) growth has been steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MBLY
- NYSE - Elec-Semicondctor Fablss
Mobileye Global Inc
|
$45.08 |
-0.93 -2.02%
|
$46.94
|
$48.11
|
-6.30% |
1,538,117 74.45%
|
2,066,000
|
Most Recent Note for MBLY - 4/19/2023 12:41:17 PM
Gapped up on the prior session for a solid gain challenging its 52-week high. Recently found support near its 50 DMA line ($41.92). Israel-based fabless Semiconductor firm completed its $21 IPO on 10/26/22. Reported earnings +125% on +59% sales revenues for the Dec '22 quarter versus the year-ago period. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NSIT
- NASDAQ - RETAIL - Catalog & Mail Order Houses
Insight Enterprises Inc
|
$126.75 |
-12.30 -8.84%
|
$134.31
|
$144.84
|
-12.49% |
567,722 184.93%
|
307,000
|
Most Recent Note for NSIT - 4/19/2023 12:43:13 PM
Gapped down today violating its 50 DMA line ($135) with a damaging volume-driven loss. Last noted with caution in the 4/06/23 mid-day report - "Perched at its all-time high, very extended from any sound base. Found support at its 50 DMA line in December and made steady progress while stubbornly holding its ground. Reported earnings +25% on -2% sales revenues for the Dec '22 quarter versus the year-ago period. Subpar sales revenues growth is a concern, fundamentally. Annual earnings (A criteria) history has been steady after a downturn in FY '13."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$165.33 |
-4.45 -2.62%
|
$165.91
|
$171.70
|
-3.71% |
903,692 67.69%
|
1,335,000
|
Most Recent Note for NVO - 4/19/2023 12:44:09 PM
This Denmark-based Medical - Ethical Drugs firm is pulling back from its all-time high today following volume-driven gains. Found prompt support after noted with caution in the 3/16/23 mid-day report when briefly undercutting its 50 DMA line - "Fundamental concerns remain. Reported Dec '22 quarterly earnings +19% on +18% sales revenues versus the year-ago period."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OLED
- NASDAQ - Elec-Misc Products
Universal Display Corp
|
$139.83 |
-3.48 -2.42%
|
$142.33
|
$155.91
|
-10.32% |
256,446 75.20%
|
341,000
|
Most Recent Note for OLED - 4/19/2023 12:45:42 PM
Sputtering near its 50 DMA line ($141.56) with today's 7th consecutive loss. Reported earnings +42% on +16% sales revenues for the Dec '22 quarter versus the year-ago period, but prior quarterly comparisons were not above the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY '20. Not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SCPL
- NASDAQ - Computer Sftwr-Gaming
Sciplay Corporation
|
$17.26 |
+0.11
0.61%
|
$17.35
|
$18.17
|
-5.04% |
545,859 105.58%
|
517,000
|
Most Recent Note for SCPL - 4/19/2023 12:46:16 PM
Reported Dec '22 quarterly earnings +256% on +18% sales revenues versus the year-ago period. Prior 4 quarterly earnings comparisons were below the year-ago periods and its annual earnings history had a downturn in FY '21. Went through a deep consolidation since last noted. Completed its $16 IPO on 5/03/19.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SNY
- NYSE - DRUGS - Drug Manufacturers - Other
Sanofi
|
$55.84 |
+0.64
1.16%
|
$55.88
|
$56.59
|
-1.33% |
1,468,258 79.49%
|
1,847,000
|
Most Recent Note for SNY - 4/19/2023 12:55:57 PM
Faces very little resistance due to overhead supply up to the $58 level. Prior mid-day reports noted - "Reported earnings +17% on +1% sales revenues for the Dec '22 quarter versus the year-ago period. Prior quarterly and annual earnings (C and A criteria) history and sales revenues growth has been below the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TSCO
- NASDAQ - SPECIALTY RETAIL - Specialty Retail, Other
Tractor Supply Co
|
$244.98 |
-0.23 -0.09%
|
$246.69
|
$245.33
|
-0.14% |
565,686 59.42%
|
952,000
|
Most Recent Note for TSCO - 4/19/2023 12:58:23 PM
Perched at its all-time high today following 4 consecutive small gains. Reported earnings +26% on +21% sales revenues for the Dec '22 quarter versus the year-ago period. Prior 6 quarterly comparisons were below the +25% minimum guideline (C criteria). Annual earnings history has been steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TTE
- NYSE - Oil&Gas-Integrated
Totalenergies S E Adr
|
$63.35 |
-0.84 -1.31%
|
$63.73
|
$65.05
|
-2.61% |
1,697,825 96.85%
|
1,753,000
|
Most Recent Note for TTE - 4/19/2023 12:59:21 PM
Pulling back today for a 3rd consecutive loss after recently challenging its 52-week high. Reported Dec '22 quarterly earnings +16% on +16% versus the year-ago period. Prior quarterly comparisons showed much stronger sales revenues and earnings increases well above the +25% minimum guideline (C criteria) over the year-ago periods. Up and down annual earnings (A criteria) history leaves fundamental concerns.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
UBS
- NYSE - BANKING - Money Center Banks
U B S Ag
|
$20.74 |
-0.27 -1.29%
|
$20.82
|
$22.30
|
-7.00% |
4,228,443 77.09%
|
5,485,000
|
Most Recent Note for UBS - 4/19/2023 1:00:34 PM
After challenging its 52-week high last week it is now consolidating back below its 50 DMA line ($20.91). Prior mid-day reports repeatedly cautioned members - "Reported Dec '22 quarterly earnings +32% on +15% sales revenues versus the year-ago period. Prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady, so it is fundamentally below guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
UMC
- NYSE - ELECTRONICS - Semiconductor - Integrated Cir
United Microelectrnc Adr
|
$8.28 |
-0.22 -2.59%
|
$8.38
|
$9.10
|
-9.01% |
4,355,706 64.51%
|
6,752,000
|
Most Recent Note for UMC - 4/19/2023 1:02:59 PM
Reported Dec '22 quarterly earnings +7% with +4% sales revenues versus the year-ago period, breaking a streak of many quarterly comparisons above the +25% minimum guideline (C criteria). Went through a deep consolidation since dropped from the Featured Stocks list on 1/26/22.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WINA
- NASDAQ - SPECIALTY RETAIL - Sporting Goods Stores
Winmark Corp
|
$330.00 |
-5.85 -1.74%
|
$335.00
|
$337.86
|
-2.33% |
11,716 58.58%
|
20,000
|
Most Recent Note for WINA - 4/19/2023 1:03:29 PM
Hovering near its all-time high following an impressive spurt higher. Prior mid-day reports repeatedly noted - "Reported Dec '22 quarterly earnings -7% on +4% sales revenues versus the year-ago period. Prior quarterly and annual earnings (C and A criteria) history has been slow and steady, not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|